Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
AMANTA
₹179.17
₹179.17
₹179.17
₹92.00
₹189.00
Markets Today
Historical Performance
As of 10-07-2026 22:21, Amanta Healthcare Ltd. share price today is ₹0, with a change of ₹-182.82 (-100.00%) from the previous close of ₹182.82. The stock opened at ₹0 and traded between ₹179.17 and ₹179.17, with a total traded volume of 8239 shares. The company has a market capitalization of ₹709.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹189 and ₹92, respectively.
Amanta Healthcare Ltd. valuation metrics include a P/E ratio of 47.7, and book value of ₹3.20. Profitability indicators show ROE of 6.75%. Amanta Healthcare Ltd. has reported revenue of ₹287.68 Cr and net profit of ₹14.88 Cr.
Amanta Healthcare Ltd. technical indicators include Day RSI at 75.24, Day MFI at 77.64, Day ADX at 37.06. Additional indicators include Commodity Channel Index (CCI) at 204.6 and Williams %R at -14.21. Momentum indicators show Day MACD at 10.98, Day MACD Signal Line at 9.03, DayATR at 8.9. Rate of Change indicators for Amanta Healthcare Ltd. include ROC125 at 66.59 and ROC21 at 34.96.
Exponential moving averages include EMA5 at ₹177.8, EMA10 at ₹171.2, EMA12 at ₹169.1, EMA20 at ₹162.2, EMA26 at ₹158.1, EMA50 at ₹146.6, EMA100 at ₹134.9, EMA200 at ₹123.1. Simple moving averages include SMA5 at ₹176.7, SMA10 at ₹168.8, SMA20 at ₹161.6, SMA30 at ₹150.7, SMA50 at ₹143.5, SMA100 at ₹125.7, SMA150 at ₹119, SMA200 at ₹121.2.
Support levels for Amanta Healthcare are placed at First Support ₹179.55, Second Support ₹176.27, Third Support ₹171.55. Resistance levels are seen at First Resistance ₹187.55, Second Resistance ₹192.27, Third Resistance ₹195.55. Amanta Healthcare Ltd. shareholding pattern shows promoter holding at 63.72%, FII holding at 0.85%, DII holding at 0%, public holding at 22.55%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 76.99 | 74.49 | 70.89 | 65.31 | 72.06 |
| Operating Expense | 62.04 | 59.13 | 56.24 | 50.41 | 53.10 |
| Operating Profit | 14.95 | 15.36 | 14.65 | 14.89 | 18.96 |
| Depreciation | 4.75 | 4.67 | 4.66 | 4.64 | 4.69 |
| Interest | 4.25 | 5.06 | 5.15 | 6.29 | 6.28 |
| Tax | 2.09 | 1.67 | 1.07 | 1.42 | 2.19 |
| Net Profit | 5.53 | 4.63 | 1.21 | 3.51 | 5.96 |
₹179.17
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|
| Promoter | 63.6 | 63.6 | 63.7 |
| FII | 1 | 1.1 | 0.8 |
| DII | 11.3 | 11.2 | 12.9 |
| Public | 24.1 | 24.1 | 22.6 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.23 L | 1.23 L | 100.00% |
| Week | 2.47 L | 2.47 L | 100.00% |
| 1 Month | 1.97 L | 5.39 L | 36.60% |
| 6 Month | 95.95 K | 1.99 L | 48.12% |
High DVM Mid and Small Caps (subscription)
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Stringent DVM Screener
Weekly Screener: High Momentum Score Stocks (subscription)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing Revenue every quarter for the past 3 quarters
Increasing profits every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
New 52 Week High
Stocks near 52 Week High with Significant Volumes
Insiders bought stocks
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹587.60 | ₹5.40 | ₹15.60 | ₹535 | ₹62 |
| % Change | -1.43% | -0.18% | 0.84% | -0.10% | -0.26% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹176.50 | ₹502.55 | ₹237.47 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹27.81 | ₹57.92 | ₹-3.28 |
| PE TTM | - | -1.30 | 29.60 | 26.70 | -103.00 |
| 1 Year Return | 52.07 | 441 | 70 | -25.38 | -41.91 |
| ROCE | 3.56 | -5.63 | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 22.67
+1.98%
Windlas Biotech Ltd.
₹ 830.00
+0.50%
Vineet Laboratories Ltd.
₹ 32.80
+0.43%
Solara Active Pharma Sciences Ltd.
₹ 568.90
+0.36%
Zim Laboratories Ltd.
₹ 113.62
-1.99%
Medico Remedies Ltd.
₹ 39.10
+0.03%
Dishman Carbogen Amcis Ltd.
₹ 195.49
+1.38%
Lasa Supergenerics Ltd.
₹ 7.52
+1.21%
Advanced Enzyme Technologies Ltd.
₹ 330.00
+1.74%
Bajaj Healthcare Ltd.
₹ 345.50
-1.31%
Ortin Global Ltd.
₹ 16.50
+1.10%
Brooks Laboratories Ltd.
₹ 69.90
-0.87%
RPG Life Sciences Ltd.
₹ 2861.10
+7.69%
Bafna Pharmaceuticals Ltd.
₹ 204.61
+2.00%
Alpa Laboratories Ltd.
₹ 68.70
+0.60%
SMS Pharmaceuticals Ltd.
₹ 403.00
-0.99%
Nectar Lifesciences Ltd.
₹ 11.21
-0.18%
Mangalam Drugs and Organics Ltd.
₹ 27.75
+1.80%
Indoco Remedies Ltd.
₹ 259.00
+1.53%
Ind-Swift Laboratories Ltd.
₹ 247.05
+4.87%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
+0.01%
Panacea Biotec Ltd.
₹ 546.00
-1.66%
Medicamen Biotech Ltd.
₹ 244.00
-0.57%
Themis Medicare Ltd.
₹ 117.59
+1.33%
By signing up I certify terms, conditions & privacy policy